Picture of Korro Bio logo

KRRO — Korro Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Frequency Therapeutics Reports Unaudited Cash, Cash Equivalents, Marketable Securities $160.5 Million

Nov 9 (Reuters) - Frequency Therapeutics Inc  FREQ.O :
    * FREQUENCY THERAPEUTICS-UNAUDITED CASH, CASH EQUIVALENTS,
MARKETABLE SECURITIES $160.5 MILLION AS OF SEPT 30, 2021, WHICH
DOES NOT INCLUDE RESTRICTED CASH

Source text: [https://bit.ly/3F3g783]
Further company coverage:  FREQ.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Korro Bio

See all news